The COVID-19 pandemic has irrevocably transformed the way beauty and wellness professionals care for and interact with their clients, and plastic surgeons are no exception. In fact, 64 percent of respondents saw an increase in their telemedicine consultations before COVID-19 began, and 68 percent started seeing patients virtually because of the pandemic. In order to better understand how plastic surgery patients’ preferences and mindsets may have changed during the pandemic, the American Society of Plastic Surgeons (ASPS) conducted a member survey based on what the professionals learned from patients during telemedicine appointments. The survey found that injectables were the most commonly asked-for treatments, with more invasive procedures at a close second. The top five were as follows:
- Botulinum Toxin Type A - 65%
- Breast Augmentation - 44%
- Soft Tissue Fillers - 37%
- Liposuction – 30%
- Abdominoplasty – 24%
With so many patients continuing to express a desire for treatments, the survey suggests that general interest has not abated, even in the pursuit of major surgeries. Says Lynn Jeffers, M.D., MBA, FACS, president of ASPS, "The early signs of patients' confidence in resuming procedures with our trusted members is a testament to why we do what we do."
Click here for the full 2019 plastic surgery statistics report.